JPWO2021041276A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021041276A5 JPWO2021041276A5 JP2022511322A JP2022511322A JPWO2021041276A5 JP WO2021041276 A5 JPWO2021041276 A5 JP WO2021041276A5 JP 2022511322 A JP2022511322 A JP 2022511322A JP 2022511322 A JP2022511322 A JP 2022511322A JP WO2021041276 A5 JPWO2021041276 A5 JP WO2021041276A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- dihydrothieno
- cyclopenta
- indazol
- pyrazole
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962891097P | 2019-08-23 | 2019-08-23 | |
| US62/891,097 | 2019-08-23 | ||
| PCT/US2020/047552 WO2021041276A1 (en) | 2019-08-23 | 2020-08-22 | Heterocyclic pyrazole derivatives as type iii receptor tyrosine kinase inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022545019A JP2022545019A (ja) | 2022-10-24 |
| JPWO2021041276A5 true JPWO2021041276A5 (cs) | 2023-08-18 |
Family
ID=74685735
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022511322A Pending JP2022545019A (ja) | 2019-08-23 | 2020-08-22 | Ｉｉｉ型受容体チロシンキナーゼ阻害剤としてのヘテロ環式ピラゾール誘導体 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220289759A1 (cs) |
| EP (1) | EP4017853A4 (cs) |
| JP (1) | JP2022545019A (cs) |
| KR (1) | KR20220051365A (cs) |
| CN (1) | CN114502553A (cs) |
| AU (1) | AU2020337883A1 (cs) |
| BR (1) | BR112022003383A2 (cs) |
| CA (1) | CA3151821A1 (cs) |
| MX (1) | MX2022002062A (cs) |
| TW (1) | TWI759829B (cs) |
| WO (1) | WO2021041276A1 (cs) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080161251A1 (en) * | 2005-01-21 | 2008-07-03 | Astex Therapeutics Limited | Pharmaceutical Compounds |
| KR20080063846A (ko) * | 2005-10-28 | 2008-07-07 | 아스트라제네카 아베 | 암 치료에서 티로신 키나제 억제제로 사용하기 위한4-(3-아미노피라졸)피리미딘 유도체 |
| JP2010505859A (ja) * | 2006-10-06 | 2010-02-25 | アイアールエム・リミテッド・ライアビリティ・カンパニー | タンパク質キナーゼ阻害剤およびそれを使用するための方法 |
| KR101122481B1 (ko) * | 2007-05-04 | 2012-02-29 | 아이알엠 엘엘씨 | Ｃ-ｋｉｔ 및 ｐｄｇｆｒ 키나제 억제제로서의 피리미딘 유도체 및 조성물 |
| EA024729B1 (ru) * | 2009-11-13 | 2016-10-31 | Джиноско | Киназные ингибиторы |
| GB201007286D0 (en) * | 2010-04-30 | 2010-06-16 | Astex Therapeutics Ltd | New compounds |
| NZ700283A (en) * | 2012-03-22 | 2016-08-26 | Oscotec Inc | Substituted pyridopyrimidine compounds and their use as flt3 inhibitors |
| US8853207B2 (en) * | 2012-04-12 | 2014-10-07 | Development Center For Biotechnology | Heterocyclic pyrazole compounds, method for preparing the same and use thereof |
| RU2018123825A (ru) * | 2015-12-07 | 2020-01-15 | Плексксикон Инк. | Соединения и способы для модуляции киназ, и показания для этого |
-
2020
- 2020-08-21 TW TW109128678A patent/TWI759829B/zh active
- 2020-08-22 US US17/636,116 patent/US20220289759A1/en active Pending
- 2020-08-22 EP EP20856905.3A patent/EP4017853A4/en active Pending
- 2020-08-22 KR KR1020227009059A patent/KR20220051365A/ko unknown
- 2020-08-22 MX MX2022002062A patent/MX2022002062A/es unknown
- 2020-08-22 AU AU2020337883A patent/AU2020337883A1/en active Pending
- 2020-08-22 WO PCT/US2020/047552 patent/WO2021041276A1/en unknown
- 2020-08-22 CN CN202080059010.6A patent/CN114502553A/zh active Pending
- 2020-08-22 CA CA3151821A patent/CA3151821A1/en active Pending
- 2020-08-22 JP JP2022511322A patent/JP2022545019A/ja active Pending
- 2020-08-22 BR BR112022003383A patent/BR112022003383A2/pt unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11964961B2 (en) | Heteroaromatic compounds and their use as dopamine D1 ligands | |
| JP6348891B2 (ja) | Ｃｘｃｒ４受容体アンタゴニスト | |
| AU2014211856B2 (en) | Substituted 2-aminopyridine protein kinase inhibitor | |
| HRP20180546T1 (hr) | Supstituirani benzilindazoli za uporabu kao inhibitori bub1 kinaze za liječenje hiperproliferativnih bolesti | |
| RU2009125897A (ru) | Ингибиторы фосфоинозитид-3-киназы и способы их применения | |
| JP2010512338A5 (cs) | ||
| AU2015275730A1 (en) | Substituted indazole compounds as IRAK4 inhibitors | |
| JP2013539777A5 (cs) | ||
| HRP20231310T1 (hr) | Heteroarilaminopirimidin amidni inhibitori autofagije i postupci njihove primjene | |
| JP6231085B2 (ja) | アミノキナゾリン誘導体及びピリドピリミジン誘導体 | |
| JP2014531465A5 (cs) | ||
| RU2008126398A (ru) | Производные гетероарилзамещенного пиперидина в качестве ингибиторов печеночной карнитин пальмитоилтрансферазы (l-cpti) | |
| EP3197883A1 (en) | Novel compounds | |
| RU2014139601A (ru) | Ингибиторы серин/треониновых киназ | |
| RU2013124101A (ru) | Гетероциклические амины и их применения | |
| JP2007508346A5 (cs) | ||
| JP2019505595A5 (cs) | ||
| RU2009105829A (ru) | СОЕДИНЕНИЯ И КОМПОЗИЦИИ В КАЧЕСТВЕ ИНГИБИТОРОВ ITPKb | |
| US9850232B2 (en) | Heteroaromatic compounds and their use as dopamine D1 ligands | |
| IL274198B1 (en) | Use of Nox inhibitors to treat cancer | |
| JPWO2020231808A5 (cs) | ||
| JP2017512184A5 (cs) | ||
| JPWO2021041276A5 (cs) | ||
| RU2022107496A (ru) | Производные гетероциклического пиразола как ингибиторы рецепторной тирозикиназы типа III | |
| WO2022246459A1 (en) | Combination therapy |